Align Capital Partners’ (“ACP”) drug and alcohol testing solutions provider Premier Biotech (“Premier” or the “Company”) has acquired National Test Systems (“NTS”), a leading provider of rapid point-of-care diagnostic drug screening supplies and services throughout the United States. NTS serves over 1,500 facilities throughout the United States, primarily in Government and Behavioral Health end markets through a consultative, knowledge-first approach. The addition of NTS enhances Premier’s customer base and strengthens the Company’s leadership within the Government and Behavioral Health channel.
Read the full article: Premier Acquires NTS to Accelerate Growth in Point-of-Care Drug Screening Services //
Source: https://www.businesswire.com/news/home/20251105086375/en/Premier-Acquires-NTS-to-Accelerate-Growth-in-Point-of-Care-Drug-Screening-Services
